866-997-4948(US-Canada Toll Free)

Global Market Study on Rare Endocrine Disease Treatment: Appropriate Treatment Evaluation and Research Collaborations to Drive Treatment Developments during 2017-2026

Published By :

Persistence Market Research

Published Date : Apr 2018

Category :

Pharmaceutical

No. of Pages : 170 Pages

A new research report of Persistence Market Research (PMR) delivers valuable intelligence on the global rare endocrine disease treatment market by providing an all-inclusive forecast on the market growth between the period 2017 and 2026. Addressing key concerns of drug makers for rare endocrine disease treatment, and reflecting impact of latest industry trends on demand for rare endocrine disease treatment, the report imparts precise analysis & forecast on the global rare endocrine disease treatment market. This report also acts as a credible business document for companies partaking in the rare endocrine disease treatment market globally.

Valuable Intelligence on Global Rare Endocrine Disease Treatment Market

This research report contains an array of distinct chapters, which provide a detailed segmentation of the global rare endocrine disease treatment market, encompassing various aspects driving the market expansion. Research findings from the report depict potential for consumer base expansion and enhancing exposure of rare endocrine disease treatment across various industrial sectors worldwide.

Impact of transforming directives related to formulation, transportation and storage of rare endocrine disease treatment has been directed toward estimating advancements in rare endocrine disease treatment in the foreseeable future. Technology trends, and industrial regulations have been unveiled by the report for increasing lucrativeness of rare endocrine disease treatment. Referring to insights offered in this report, drug makers of rare endocrine disease treatment can formulate methods for expanding their businesses globally beyond conventional margins.

As the identification of untapped opportunities in the global rare endocrine disease treatment market has prevailed as a major challenge for the market participants, this report offers analysis that discloses these opportunities. Intelligence provided in the report will enable companies developing treatment options for rare endocrine disease in making modified decisions for profitable and long-term business expansion.

Market Analysis & Research Methodology

Considering the lucrativeness of rare endocrine disease treatment and its fluctuating cost, data points have been rendered in the report, with which the market players will be able to minimize risks. Offering in-depth insights on regions and countries lucrative for the market growth, companies are enabled to re-strategize their global measures. Continuous discussions with leading industry experts along with references of authentic databases are key methods employed by PMRs analysts for harnessing baseline information to forecast the market size.

Data obtained has been collated for creating a framework on demand evolution of rare endocrine disease treatment in the upcoming years. A tested & proven research methodology has been employed by the analysts for projecting growth prospects of the global market for rare endocrine disease treatment across multiple market parameters. Quantitative data has been combined with qualitative information in a bid to enhance accuracy of the market size evaluations forecast.

Competition Landscape Analysis

Leading companies in global rare endocrine disease treatment market are profiled in the reports concluding chapter. Companies can avail this report for assessing their current market standing, and understanding opportunities for enhancing their reputation. Supply chain complexities, formulation challenges, and pricing volatility are addressed and analyzed in this chapter for resolving key concerns of the market players. Competition landscape analysis issued in this chapter is priceless for emerging market players. Novel strategies employed by the market leaders are disclosed in this chapter, which provides the first-hand information on establishment strategies that can be leveraged by niche companies partaking in the global rare endocrine disease treatment market.
1. Global Economic Outlook

2. Global Rare Endocrine Disease Treatment Market - Executive Summary

3. Global Rare Endocrine Disease Treatment Market Overview
3.1. Introduction
3.1.1. Global Rare Endocrine Disease Treatment Market Taxonomy
3.1.2. Global Rare Endocrine Disease Treatment Market Definition
3.2. Global Rare Endocrine Disease Treatment Market Size (US$ Mn) and Forecast, 2012-2026
3.2.1. Global Rare Endocrine Disease Treatment Market Y-o-Y Growth
3.3. Global Rare Endocrine Disease Treatment Market Dynamics
3.4. Supply Chain
3.5. Cost Structure
3.6. USA, EU & Japan Orphan Designations per Year & Cumulative (1983 2016)
3.7. Worldwide Top 20 Orphan Drug Manufacturers (2016 2022)
3.8. Wheel of Fortune
3.9. Rare Disease Key Regulations
3.9.1. Rare Disease Key Regulations: North America
3.9.2. Rare Disease Key Regulations: Latin America
3.9.3. Rare Disease Key Regulations: Europe
3.9.4. Rare Disease Key Regulations: Asia Pacific
3.9.5. Rare Disease Key Regulations: Middle East & Africa
3.10. Forecast Scenario
3.11. PEST Analysis
3.12. Porter's Five Forces Analysis
3.13. Market Positioning and Behavioral Assessment
3.14. Investment Feasibility Assessment
3.15. Competitor Market Footprint Matrix
3.16. Key Participants Market Presence (Intensity Map) By Region

4. Global Rare Endocrine Disease Treatment Market Analysis and Forecast 2012-2026
4.1. Global Rare Endocrine Disease Treatment Market Size and Forecast By Indication, 2012-2026
4.1.1. Acromegaly Market Size and Forecast, 2012-2026
4.1.1.1. Revenue (US$ Mn) Comparison, By Region
4.1.1.2. Market Share Comparison, By Region
4.1.1.3. Y-o-Y growth Comparison, By Region
4.1.2. Central Diabetes Insipidus Market Size and Forecast, 2012-2026
4.1.2.1. Revenue (US$ Mn) Comparison, By Region
4.1.2.2. Market Share Comparison, By Region
4.1.2.3. Y-o-Y growth Comparison, By Region
4.1.3. Ahumada-Del Castillo Syndrome Market Size and Forecast, 2012-2026
4.1.3.1. Revenue (US$ Mn) Comparison, By Region
4.1.3.2. Market Share Comparison, By Region
4.1.3.3. Y-o-Y growth Comparison, By Region
4.1.4. Hypoparathyroidism Market Size and Forecast, 2012-2026
4.1.4.1. Revenue (US$ Mn) Comparison, By Region
4.1.4.2. Market Share Comparison, By Region
4.1.4.3. Y-o-Y growth Comparison, By Region
4.1.5. Other Indications Market Size and Forecast, 2012-2026
4.1.5.1. Revenue (US$ Mn) Comparison, By Region
4.1.5.2. Market Share Comparison, By Region
4.1.5.3. Y-o-Y growth Comparison, By Region
4.2. Global Rare Endocrine Disease Treatment Market Size and Forecast By Drug Type, 2012-2026
4.2.1. Biologics Market Size and Forecast, 2012-2026
4.2.1.1. Revenue (US$ Mn) Comparison, By Region
4.2.1.2. Market Share Comparison, By Region
4.2.1.3. Y-o-Y growth Comparison, By Region
4.2.2. Organic Compounds Market Size and Forecast, 2012-2026
4.2.2.1. Revenue (US$ Mn) Comparison, By Region
4.2.2.2. Market Share Comparison, By Region
4.2.2.3. Y-o-Y growth Comparison, By Region
4.3. Global Rare Endocrine Disease Treatment Market Size and Forecast By Mode of Administration, 2012-2026
4.3.1. Injectables Market Size and Forecast, 2012-2026
4.3.1.1. Revenue (US$ Mn) Comparison, By Region
4.3.1.2. Market Share Comparison, By Region
4.3.1.3. Y-o-Y growth Comparison, By Region
4.3.2. Oral Market Size and Forecast, 2012-2026
4.3.2.1. Revenue (US$ Mn) Comparison, By Region
4.3.2.2. Market Share Comparison, By Region
4.3.2.3. Y-o-Y growth Comparison, By Region
4.3.3. Others Market Size and Forecast, 2012-2026
4.3.3.1. Revenue (US$ Mn) Comparison, By Region
4.3.3.2. Market Share Comparison, By Region
4.3.3.3. Y-o-Y growth Comparison, By Region
4.4. Global Rare Endocrine Disease Treatment Market Size and Forecast By Distribution Channel, 2012-2026
4.4.1. Hospital Pharmacies Market Size and Forecast, 2012-2026
4.4.1.1. Revenue (US$ Mn) Comparison, By Region
4.4.1.2. Market Share Comparison, By Region
4.4.1.3. Y-o-Y growth Comparison, By Region
4.4.2. Retail Pharmacies Market Size and Forecast, 2012-2026
4.4.2.1. Revenue (US$ Mn) Comparison, By Region
4.4.2.2. Market Share Comparison, By Region
4.4.2.3. Y-o-Y growth Comparison, By Region
4.4.3. Online Pharmacies Market Size and Forecast, 2012-2026
4.4.3.1. Revenue (US$ Mn) Comparison, By Region
4.4.3.2. Market Share Comparison, By Region
4.4.3.3. Y-o-Y growth Comparison, By Region

5. North America Rare Endocrine Disease Treatment Market Size and Forecast, 2012-2026
5.1. North America Outlook
5.2. North America Parent Market Outlook
5.3. North America Target Market Outlook
5.4. Revenue (US$ Mn) Comparison, By Country
5.4.1. US Market Size and Forecast (US$ Mn), 2012-2026
5.4.2. Canada Market Size and Forecast (US$ Mn), 2012-2026
5.5. Revenue (US$ Mn) Comparison, By Indication
5.6. Revenue (US$ Mn) Comparison, By Drug Type
5.7. Revenue (US$ Mn) Comparison, By Mode of Administration
5.8. Revenue (US$ Mn) Comparison, By Distribution Channel

6. Latin America Rare Endocrine Disease Treatment Market Size and Forecast, 2012-2026
6.1. Latin America Outlook
6.2. Latin America Parent Market Outlook
6.3. Latin America Target Market Outlook
6.4. Revenue (US$ Mn) Comparison, By Country
6.4.1. Brazil Market Size and Forecast (US$ Mn), 2012-2026
6.4.2. Mexico Market Size and Forecast (US$ Mn), 2012-2026
6.4.3. Rest of Latin America Market Size and Forecast (US$ Mn), 2012-2026
6.5. Revenue (US$ Mn) Comparison, By Indication
6.6. Revenue (US$ Mn) Comparison, By Drug Type
6.7. Revenue (US$ Mn) Comparison, By Mode of Administration
6.8. Revenue (US$ Mn) Comparison, By Distribution Channel

7. Europe Rare Endocrine Disease Treatment Market Size and Forecast, 2012-2026
7.1. Europe Outlook
7.2. Europe Parent Market Outlook
7.3. Europe Target Market Outlook
7.4. Revenue (US$ Mn) Comparison, By Country
7.4.1. Germany Market Size and Forecast (US$ Mn), 2012-2026
7.4.2. UK Market Size and Forecast (US$ Mn), 2012-2026
7.4.3. France Market Size and Forecast (US$ Mn), 2012-2026
7.4.4. Spain Market Size and Forecast (US$ Mn), 2012-2026
7.4.5. Italy Market Size and Forecast (US$ Mn), 2012-2026
7.4.6. Rest of Europe Market Size and Forecast (US$ Mn), 2012-2026
7.5. Revenue (US$ Mn) Comparison, By Indication
7.6. Revenue (US$ Mn) Comparison, By Drug Type
7.7. Revenue (US$ Mn) Comparison, By Mode of Administration
7.8. Revenue (US$ Mn) Comparison, By Distribution Channel

8. Japan Rare Endocrine Disease Treatment Market Size and Forecast, 2012-2026
8.1. Japan Outlook
8.2. Japan Parent Market Outlook
8.3. Japan Target Market Outlook
8.4. Japan Market Size and Forecast (US$ Mn), 2012-2026
8.5. Revenue (US$ Mn) Comparison, By Indication
8.6. Revenue (US$ Mn) Comparison, By Drug Type
8.7. Revenue (US$ Mn) Comparison, By Mode of Administration
8.8. Revenue (US$ Mn) Comparison, By Distribution Channel

9. APEJ Rare Endocrine Disease Treatment Market Size and Forecast, 2012-2026
9.1. APEJ Outlook
9.2. APEJ Parent Market Outlook
9.3. APEJ Target Market Outlook
9.4. Revenue (US$ Mn) Comparison, By Country
9.4.1. China Market Size and Forecast (US$ Mn), 2012-2026
9.4.2. India Market Size and Forecast (US$ Mn), 2012-2026
9.4.3. Thailand Market Size and Forecast (US$ Mn), 2012-2026
9.4.4. Singapore Market Size and Forecast (US$ Mn), 2012-2026
9.4.5. Australia Market Size and Forecast (US$ Mn), 2012-2026
9.4.6. Rest of APEJ Market Size and Forecast (US$ Mn), 2012-2026
9.5. Revenue (US$ Mn) Comparison, By Indication
9.6. Revenue (US$ Mn) Comparison, By Drug Type
9.7. Revenue (US$ Mn) Comparison, By Mode of Administration
9.8. Revenue (US$ Mn) Comparison, By Distribution Channel

10. MEA Rare Endocrine Disease Treatment Market Size and Forecast, 2012-2026
10.1. MEA Outlook
10.2. MEA Parent Market Outlook
10.3. MEA Target Market Outlook
10.4. Revenue (US$ Mn) Comparison, By Country
10.4.1. GCC Countries Market Size and Forecast (US$ Mn), 2012-2026
10.4.2. South Africa Market Size and Forecast (US$ Mn), 2012-2026
10.4.3. Nigeria Market Size and Forecast (US$ Mn), 2012-2026
10.4.4. Rest of MEA Market Size and Forecast (US$ Mn), 2012-2026
10.5. Revenue (US$ Mn) Comparison, By Indication
10.6. Revenue (US$ Mn) Comparison, By Drug Type
10.7. Revenue (US$ Mn) Comparison, By Mode of Administration
10.8. Revenue (US$ Mn) Comparison, By Distribution Channel

11. Global Rare Endocrine Disease Treatment Market Company Share, Competition Landscape and Company Profiles
11.1. Company Share Analysis
11.2. Competition Landscape
11.3. Company Profiles
11.3.1. Novartis
11.3.2. Ipsen
11.3.3. Pfizer, Inc.
11.3.4. Teva
11.3.5. EMD serono
11.3.6. Novo Nordisk
11.3.7. Eli Lilly
11.3.8. Shire
11.3.9. Amgen, Inc.
11.3.10. Corcept Therapeutics
11.3.11. Novelion Therapeutics

12. Key Takeaways

13. Research Methodology

14. Disclaimer

List of Table

List of Table

TABLE 1 Global Rare Endocrine Disease Treatment Market Value (US$ Mn), 2012-2017
TABLE 2 Global Rare Endocrine Disease Treatment Market Value (US$ Mn), 2018-2026
TABLE 3 Global Rare Endocrine Disease Treatment Market Value (US$ Mn) and Y-o-Y, 2017-2026
TABLE 4 Global Acromegaly Segment Value (US$ Mn), By Region 2012-2017
TABLE 5 Global Acromegaly Segment Value (US$ Mn), By Region 2018-2026
TABLE 6 Global Acromegaly Segment Market Share, By Region 2012-2017
TABLE 7 Global Acromegaly Segment Market Share, By Region 2018-2026
TABLE 8 Global Acromegaly Segment Y-o-Y, By Region 2017-2026
TABLE 9 Global Central Diabetes Insipidus Segment Value (US$ Mn), By Region 2012-2017
TABLE 10 Global Central Diabetes Insipidus Segment Value (US$ Mn), By Region 2018-2026
TABLE 11 Global Central Diabetes Insipidus Segment Market Share, By Region 2012-2017
TABLE 12 Global Central Diabetes Insipidus Segment Market Share, By Region 2018-2026
TABLE 13 Global Central Diabetes Insipidus Segment Y-o-Y, By Region 2017-2026
TABLE 14 Global Ahumada-Del Castillo Syndrome Segment Value (US$ Mn), By Region 2012-2017
TABLE 15 Global Ahumada-Del Castillo Syndrome Segment Value (US$ Mn), By Region 2018-2026
TABLE 16 Global Ahumada-Del Castillo Syndrome Segment Market Share, By Region 2012-2017
TABLE 17 Global Ahumada-Del Castillo Syndrome Segment Market Share, By Region 2018-2026
TABLE 18 Global Ahumada-Del Castillo Syndrome Segment Y-o-Y, By Region 2017-2026
TABLE 19 Global Hypoparathyroidism Segment Value (US$ Mn), By Region 2012-2017
TABLE 20 Global Hypoparathyroidism Segment Value (US$ Mn), By Region 2018-2026
TABLE 21 Global Hypoparathyroidism Segment Market Share, By Region 2012-2017
TABLE 22 Global Hypoparathyroidism Segment Market Share, By Region 2018-2026
TABLE 23 Global Hypoparathyroidism Segment Y-o-Y, By Region 2017-2026
TABLE 24 Global Other Indications Segment Value (US$ Mn), By Region 2012-2017
TABLE 25 Global Other Indications Segment Value (US$ Mn), By Region 2018-2026
TABLE 26 Global Other Indications Segment Market Share, By Region 2012-2017
TABLE 27 Global Other Indications Segment Market Share, By Region 2018-2026
TABLE 28 Global Other Indications Segment Y-o-Y, By Region 2017-2026
TABLE 29 Global Biologics Segment Value (US$ Mn), By Region 2012-2017
TABLE 30 Global Biologics Segment Value (US$ Mn), By Region 2018-2026
TABLE 31 Global Biologics Segment Market Share, By Region 2012-2017
TABLE 32 Global Biologics Segment Market Share, By Region 2018-2026
TABLE 33 Global Biologics Segment Y-o-Y, By Region 2017-2026
TABLE 34 Global Organic Compounds Segment Value (US$ Mn), By Region 2012-2017
TABLE 35 Global Organic Compounds Segment Value (US$ Mn), By Region 2018-2026
TABLE 36 Global Organic Compounds Segment Market Share, By Region 2012-2017
TABLE 37 Global Organic Compounds Segment Market Share, By Region 2018-2026
TABLE 38 Global Organic Compounds Segment Y-o-Y, By Region 2017-2026
TABLE 39 Global Injectables Segment Value (US$ Mn), By Region 2012-2017
TABLE 40 Global Injectables Segment Value (US$ Mn), By Region 2018-2026
TABLE 41 Global Injectables Segment Market Share, By Region 2012-2017
TABLE 42 Global Injectables Segment Market Share, By Region 2018-2026
TABLE 43 Global Injectables Segment Y-o-Y, By Region 2017-2026
TABLE 44 Global Oral Segment Value (US$ Mn), By Region 2012-2017
TABLE 45 Global Oral Segment Value (US$ Mn), By Region 2018-2026
TABLE 46 Global Oral Segment Market Share, By Region 2012-2017
TABLE 47 Global Oral Segment Market Share, By Region 2018-2026
TABLE 48 Global Oral Segment Y-o-Y, By Region 2017-2026
TABLE 49 Global Others Segment Value (US$ Mn), By Region 2012-2017
TABLE 50 Global Others Segment Value (US$ Mn), By Region 2018-2026
TABLE 51 Global Others Segment Market Share, By Region 2012-2017
TABLE 52 Global Others Segment Market Share, By Region 2018-2026
TABLE 53 Global Others Segment Y-o-Y, By Region 2017-2026
TABLE 54 Global Hospital Pharmacies Segment Value (US$ Mn), By Region 2012-2017
TABLE 55 Global Hospital Pharmacies Segment Value (US$ Mn), By Region 2018-2026
TABLE 56 Global Hospital Pharmacies Segment Market Share, By Region 2012-2017
TABLE 57 Global Hospital Pharmacies Segment Market Share, By Region 2018-2026
TABLE 58 Global Hospital Pharmacies Segment Y-o-Y, By Region 2017-2026
TABLE 59 Global Retail Pharmacies Segment Value (US$ Mn), By Region 2012-2017
TABLE 60 Global Retail Pharmacies Segment Value (US$ Mn), By Region 2018-2026
TABLE 61 Global Retail Pharmacies Segment Market Share, By Region 2012-2017
TABLE 62 Global Retail Pharmacies Segment Market Share, By Region 2018-2026
TABLE 63 Global Retail Pharmacies Segment Y-o-Y, By Region 2017-2026
TABLE 64 Global Online Pharmacies Segment Value (US$ Mn), By Region 2012-2017
TABLE 65 Global Online Pharmacies Segment Value (US$ Mn), By Region 2018-2026
TABLE 66 Global Online Pharmacies Segment Market Share, By Region 2012-2017
TABLE 67 Global Online Pharmacies Segment Market Share, By Region 2018-2026
TABLE 68 Global Online Pharmacies Segment Y-o-Y, By Region 2017-2026
TABLE 69 North America Rare Endocrine Disease Treatment Market Value (US$ Mn), By Country 2012-2017
TABLE 70 North America Rare Endocrine Disease Treatment Market Value (US$ Mn), By Country 2018-2026
TABLE 71 North America Rare Endocrine Disease Treatment Market Value (US$ Mn), By Indication 2012-2017
TABLE 72 North America Rare Endocrine Disease Treatment Market Value (US$ Mn), By Indication 2018-2026
TABLE 73 North America Rare Endocrine Disease Treatment Market Value (US$ Mn), By Drug Type 2012-2017
TABLE 74 North America Rare Endocrine Disease Treatment Market Value (US$ Mn), By Drug Type 2018-2026
TABLE 75 North America Rare Endocrine Disease Treatment Market Value (US$ Mn), By Mode of Administration 2012-2017
TABLE 76 North America Rare Endocrine Disease Treatment Market Value (US$ Mn), By Mode of Administration 2018-2026
TABLE 77 North America Rare Endocrine Disease Treatment Market Value (US$ Mn), By Distribution Channel 2012-2017
TABLE 78 North America Rare Endocrine Disease Treatment Market Value (US$ Mn), By Distribution Channel 2018-2026
TABLE 79 Latin America Rare Endocrine Disease Treatment Market Value (US$ Mn), By Country 2012-2017
TABLE 80 Latin America Rare Endocrine Disease Treatment Market Value (US$ Mn), By Country 2018-2026
TABLE 81 Latin America Rare Endocrine Disease Treatment Market Value (US$ Mn), By Indication 2012-2017
TABLE 82 Latin America Rare Endocrine Disease Treatment Market Value (US$ Mn), By Indication 2018-2026
TABLE 83 Latin America Rare Endocrine Disease Treatment Market Value (US$ Mn), By Drug Type 2012-2017
TABLE 84 Latin America Rare Endocrine Disease Treatment Market Value (US$ Mn), By Drug Type 2018-2026
TABLE 85 Latin America Rare Endocrine Disease Treatment Market Value (US$ Mn), By Mode of Administration 2012-2017
TABLE 86 Latin America Rare Endocrine Disease Treatment Market Value (US$ Mn), By Mode of Administration 2018-2026
TABLE 87 Latin America Rare Endocrine Disease Treatment Market Value (US$ Mn), By Distribution Channel 2012-2017
TABLE 88 Latin America Rare Endocrine Disease Treatment Market Value (US$ Mn), By Distribution Channel 2018-2026
TABLE 89 Europe Rare Endocrine Disease Treatment Market Value (US$ Mn), By Country 2012-2017
TABLE 90 Europe Rare Endocrine Disease Treatment Market Value (US$ Mn), By Country 2018-2026
TABLE 91 Europe Rare Endocrine Disease Treatment Market Value (US$ Mn), By Indication 2012-2017
TABLE 92 Europe Rare Endocrine Disease Treatment Market Value (US$ Mn), By Indication 2018-2026
TABLE 93 Europe Rare Endocrine Disease Treatment Market Value (US$ Mn), By Drug Type 2012-2017
TABLE 94 Europe Rare Endocrine Disease Treatment Market Value (US$ Mn), By Drug Type 2018-2026
TABLE 95 Europe Rare Endocrine Disease Treatment Market Value (US$ Mn), By Mode of Administration 2012-2017
TABLE 96 Europe Rare Endocrine Disease Treatment Market Value (US$ Mn), By Mode of Administration 2018-2026
TABLE 97 Europe Rare Endocrine Disease Treatment Market Value (US$ Mn), By Distribution Channel 2012-2017
TABLE 98 Europe Rare Endocrine Disease Treatment Market Value (US$ Mn), By Distribution Channel 2018-2026
TABLE 99 Japan Rare Endocrine Disease Treatment Market Value (US$ Mn), By Country 2012-2017
TABLE 100 Japan Rare Endocrine Disease Treatment Market Value (US$ Mn), By Country 2018-2026
TABLE 101 Japan Rare Endocrine Disease Treatment Market Value (US$ Mn), By Indication 2012-2017
TABLE 102 Japan Rare Endocrine Disease Treatment Market Value (US$ Mn), By Indication 2018-2026
TABLE 103 Japan Rare Endocrine Disease Treatment Market Value (US$ Mn), By Drug Type 2012-2017
TABLE 104 Japan Rare Endocrine Disease Treatment Market Value (US$ Mn), By Drug Type 2018-2026
TABLE 105 Japan Rare Endocrine Disease Treatment Market Value (US$ Mn), By Mode of Administration 2012-2017
TABLE 106 Japan Rare Endocrine Disease Treatment Market Value (US$ Mn), By Mode of Administration 2018-2026
TABLE 107 Japan Rare Endocrine Disease Treatment Market Value (US$ Mn), By Distribution Channel 2012-2017
TABLE 108 Japan Rare Endocrine Disease Treatment Market Value (US$ Mn), By Distribution Channel 2018-2026
TABLE 109 APEJ Rare Endocrine Disease Treatment Market Value (US$ Mn), By Country 2012-2017
TABLE 110 APEJ Rare Endocrine Disease Treatment Market Value (US$ Mn), By Country 2018-2026
TABLE 111 APEJ Rare Endocrine Disease Treatment Market Value (US$ Mn), By Indication 2012-2017
TABLE 112 APEJ Rare Endocrine Disease Treatment Market Value (US$ Mn), By Indication 2018-2026
TABLE 113 APEJ Rare Endocrine Disease Treatment Market Value (US$ Mn), By Drug Type 2012-2017
TABLE 114 APEJ Rare Endocrine Disease Treatment Market Value (US$ Mn), By Drug Type 2018-2026
TABLE 115 APEJ Rare Endocrine Disease Treatment Market Value (US$ Mn), By Mode of Administration 2012-2017
TABLE 116 APEJ Rare Endocrine Disease Treatment Market Value (US$ Mn), By Mode of Administration 2018-2026
TABLE 117 APEJ Rare Endocrine Disease Treatment Market Value (US$ Mn), By Distribution Channel 2012-2017
TABLE 118 APEJ Rare Endocrine Disease Treatment Market Value (US$ Mn), By Distribution Channel 2018-2026
TABLE 119 MEA Rare Endocrine Disease Treatment Market Value (US$ Mn), By Country 2012-2017
TABLE 120 MEA Rare Endocrine Disease Treatment Market Value (US$ Mn), By Country 2018-2026
TABLE 121 MEA Rare Endocrine Disease Treatment Market Value (US$ Mn), By Indication 2012-2017
TABLE 122 MEA Rare Endocrine Disease Treatment Market Value (US$ Mn), By Indication 2018-2026
TABLE 123 MEA Rare Endocrine Disease Treatment Market Value (US$ Mn), By Drug Type 2012-2017
TABLE 124 MEA Rare Endocrine Disease Treatment Market Value (US$ Mn), By Drug Type 2018-2026
TABLE 125 MEA Rare Endocrine Disease Treatment Market Value (US$ Mn), By Mode of Administration 2012-2017
TABLE 126 MEA Rare Endocrine Disease Treatment Market Value (US$ Mn), By Mode of Administration 2018-2026
TABLE 127 MEA Rare Endocrine Disease Treatment Market Value (US$ Mn), By Distribution Channel 2012-2017
TABLE 128 MEA Rare Endocrine Disease Treatment Market Value (US$ Mn), By Distribution Channel 2018-2026

List of Chart

List of Figure

FIG. 1 Global Rare Endocrine Disease Treatment Market Value (US$ Mn), 2012-2017
FIG. 2 Global Rare Endocrine Disease Treatment Market Value (US$ Mn) Forecast, 2018-2026
FIG. 3 Global Rare Endocrine Disease Treatment Market Value (US$ Mn) and Y-o-Y, 2017-2026
FIG. 4 Global Acromegaly Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 5 Global Acromegaly Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 6 Global Acromegaly Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 7 Global Central Diabetes Insipidus Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 8 Global Central Diabetes Insipidus Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 9 Global Central Diabetes Insipidus Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 10 Global Ahumada-Del Castillo Syndrome Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 11 Global Ahumada-Del Castillo Syndrome Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 12 Global Ahumada-Del Castillo Syndrome Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 13 Global Hypoparathyroidism Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 14 Global Hypoparathyroidism Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 15 Global Hypoparathyroidism Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 16 Global Other Indications Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 17 Global Other Indications Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 18 Global Other Indications Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 19 Global Biologics Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 20 Global Biologics Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 21 Global Biologics Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 22 Global Organic Compounds Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 23 Global Organic Compounds Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 24 Global Organic Compounds Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 25 Global Injectables Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 26 Global Injectables Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 27 Global Injectables Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 28 Global Oral Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 29 Global Oral Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 30 Global Oral Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 31 Global Others Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 32 Global Others Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 33 Global Others Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 34 Global Hospital Pharmacies Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 35 Global Hospital Pharmacies Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 36 Global Hospital Pharmacies Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 37 Global Retail Pharmacies Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 38 Global Retail Pharmacies Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 39 Global Retail Pharmacies Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 40 Global Online Pharmacies Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 41 Global Online Pharmacies Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 42 Global Online Pharmacies Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 43 North America Rare Endocrine Disease Treatment Market Value (US$ Mn), By Country 2012-2017
FIG. 44 North America Rare Endocrine Disease Treatment Market Value (US$ Mn), By Country 2018-2026
FIG. 45 North America Rare Endocrine Disease Treatment Market Value (US$ Mn), By Indication 2012-2017
FIG. 46 North America Rare Endocrine Disease Treatment Market Value (US$ Mn), By Indication 2018-2026
FIG. 47 North America Rare Endocrine Disease Treatment Market Value (US$ Mn), By Drug Type 2012-2017
FIG. 48 North America Rare Endocrine Disease Treatment Market Value (US$ Mn), By Drug Type 2018-2026
FIG. 49 North America Rare Endocrine Disease Treatment Market Value (US$ Mn), By Mode of Administration 2012-2017
FIG. 50 North America Rare Endocrine Disease Treatment Market Value (US$ Mn), By Mode of Administration 2018-2026
FIG. 51 North America Rare Endocrine Disease Treatment Market Value (US$ Mn), By Distribution Channel 2012-2017
FIG. 52 North America Rare Endocrine Disease Treatment Market Value (US$ Mn), By Distribution Channel 2018-2026
FIG. 53 Latin America Rare Endocrine Disease Treatment Market Value (US$ Mn), By Country 2012-2017
FIG. 54 Latin America Rare Endocrine Disease Treatment Market Value (US$ Mn), By Country 2018-2026
FIG. 55 Latin America Rare Endocrine Disease Treatment Market Value (US$ Mn), By Indication 2012-2017
FIG. 56 Latin America Rare Endocrine Disease Treatment Market Value (US$ Mn), By Indication 2018-2026
FIG. 57 Latin America Rare Endocrine Disease Treatment Market Value (US$ Mn), By Drug Type 2012-2017
FIG. 58 Latin America Rare Endocrine Disease Treatment Market Value (US$ Mn), By Drug Type 2018-2026
FIG. 59 Latin America Rare Endocrine Disease Treatment Market Value (US$ Mn), By Mode of Administration 2012-2017
FIG. 60 Latin America Rare Endocrine Disease Treatment Market Value (US$ Mn), By Mode of Administration 2018-2026
FIG. 61 Latin America Rare Endocrine Disease Treatment Market Value (US$ Mn), By Distribution Channel 2012-2017
FIG. 62 Latin America Rare Endocrine Disease Treatment Market Value (US$ Mn), By Distribution Channel 2018-2026
FIG. 63 Europe Rare Endocrine Disease Treatment Market Value (US$ Mn), By Country 2012-2017
FIG. 64 Europe Rare Endocrine Disease Treatment Market Value (US$ Mn), By Country 2018-2026
FIG. 65 Europe Rare Endocrine Disease Treatment Market Value (US$ Mn), By Indication 2012-2017
FIG. 66 Europe Rare Endocrine Disease Treatment Market Value (US$ Mn), By Indication 2018-2026
FIG. 67 Europe Rare Endocrine Disease Treatment Market Value (US$ Mn), By Drug Type 2012-2017
FIG. 68 Europe Rare Endocrine Disease Treatment Market Value (US$ Mn), By Drug Type 2018-2026
FIG. 69 Europe Rare Endocrine Disease Treatment Market Value (US$ Mn), By Mode of Administration 2012-2017
FIG. 70 Europe Rare Endocrine Disease Treatment Market Value (US$ Mn), By Mode of Administration 2018-2026
FIG. 71 Europe Rare Endocrine Disease Treatment Market Value (US$ Mn), By Distribution Channel 2012-2017
FIG. 72 Europe Rare Endocrine Disease Treatment Market Value (US$ Mn), By Distribution Channel 2018-2026
FIG. 73 Japan Rare Endocrine Disease Treatment Market Value (US$ Mn), By Country 2012-2017
FIG. 74 Japan Rare Endocrine Disease Treatment Market Value (US$ Mn), By Country 2018-2026
FIG. 75 Japan Rare Endocrine Disease Treatment Market Value (US$ Mn), By Indication 2012-2017
FIG. 76 Japan Rare Endocrine Disease Treatment Market Value (US$ Mn), By Indication 2018-2026
FIG. 77 Japan Rare Endocrine Disease Treatment Market Value (US$ Mn), By Mode of Administration 2012-2017
FIG. 78 Japan Rare Endocrine Disease Treatment Market Value (US$ Mn), By Drug Type 2018-2026
FIG. 79 Japan Rare Endocrine Disease Treatment Market Value (US$ Mn), By Mode of Administration 2012-2017
FIG. 80 Japan Rare Endocrine Disease Treatment Market Value (US$ Mn), By Mode of Administration 2018-2026
FIG. 81 Japan Rare Endocrine Disease Treatment Market Value (US$ Mn), By Distribution Channel 2012-2017
FIG. 82 Japan Rare Endocrine Disease Treatment Market Value (US$ Mn), By Distribution Channel 2018-2026
FIG. 83 APEJ Rare Endocrine Disease Treatment Market Value (US$ Mn), By Country 2012-2017
FIG. 84 APEJ Rare Endocrine Disease Treatment Market Value (US$ Mn), By Country 2018-2026
FIG. 85 APEJ Rare Endocrine Disease Treatment Market Value (US$ Mn), By Indication 2012-2017
FIG. 86 APEJ Rare Endocrine Disease Treatment Market Value (US$ Mn), By Indication 2018-2026
FIG. 87 APEJ Rare Endocrine Disease Treatment Market Value (US$ Mn), By Drug Type 2012-2017
FIG. 88 APEJ Rare Endocrine Disease Treatment Market Value (US$ Mn), By Drug Type 2018-2026
FIG. 89 APEJ Rare Endocrine Disease Treatment Market Value (US$ Mn), By Mode of Administration 2012-2017
FIG. 90 APEJ Rare Endocrine Disease Treatment Market Value (US$ Mn), By Mode of Administration 2018-2026
FIG. 91 APEJ Rare Endocrine Disease Treatment Market Value (US$ Mn), By Distribution Channel 2012-2017
FIG. 92 APEJ Rare Endocrine Disease Treatment Market Value (US$ Mn), By Distribution Channel 2018-2026
FIG. 93 MEA Rare Endocrine Disease Treatment Market Value (US$ Mn), By Country 2012-2017
FIG. 94 MEA Rare Endocrine Disease Treatment Market Value (US$ Mn), By Country 2018-2026
FIG. 95 MEA Rare Endocrine Disease Treatment Market Value (US$ Mn), By Indication 2012-2017
FIG. 96 MEA Rare Endocrine Disease Treatment Market Value (US$ Mn), By Indication 2018-2026
FIG. 97 MEA Rare Endocrine Disease Treatment Market Value (US$ Mn), By Drug Type 2012-2017
FIG. 98 MEA Rare Endocrine Disease Treatment Market Value (US$ Mn), By Drug Type 2018-2026
FIG. 99 MEA Rare Endocrine Disease Treatment Market Value (US$ Mn), By Mode of Administration 2012-2017
FIG. 100 MEA Rare Endocrine Disease Treatment Market Value (US$ Mn), By Mode of Administration 2018-2026
FIG. 101 MEA Rare Endocrine Disease Treatment Market Value (US$ Mn), By Distribution Channel 2012-2017
FIG. 102 MEA Rare Endocrine Disease Treatment Market Value (US$ Mn), By Distribution Channel 2018-2026

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *